Independent Sector Cancer Network (ISCN) Publish NEW Cancer Service Guidelines

The Independent Sector Cancer Network (ISCN) is a strategic quality governance and safety group which aims to improve independard sector cancer provision though effective collaboration and sharing of best practice across the Independent Sector Cancer Services within the UK.

The ISCN is comprised of expert members who are senior leaders in cancer care, representing nursing, therapeutic radiology, and pharmacy. Over the past years, our team has diligently worked on developing these guidelines to be implemented across the independent sector, aiming to standardise and elevate clinical practice. Although led by the ISCN, this document has transferability to all cancer services.

The ISCN Cancer Service Guidelines 2024 are now readily available for use. These guidelines are designed to:

  • Guide quality of care in practice: Providing a comprehensive framework to ensure the highest standards of patient care.
  • Offer a benchmarking framework: Enabling teams to measure and compare their practices against established standards.
  • Standardize clinical practice: Ensuring consistency and excellence in cancer care across the independent sector.

The ISCN believes these guidelines will significantly contribute to improving patient outcomes and fostering a culture of continuous improvement in cancer care. The ISCN would encourage all teams to integrate these guidelines into their daily practice and use them as a tool for achieving excellence in patient care.

To access the guidelines please click here: https://www.bopa.org.uk/resources/iscn-cancer-service-guidelines/

Please note you need to be a free or paid member of BOPA to access.

Thank you for your commitment to advancing cancer care.

Best regards,
Independent Sector Cancer Network (ISCN)

Latest News

By BOPA Education & Training Subcommittee on 12th June 2026

BOPA Publication – Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative 

Cancer pharmacists and consultant credentialing in Great Britain: an analysis of influencing factors and the impact of a dedicated support initiative  The study explored factors influencing cancer pharmacists’ progression through…

Read article
By BOPA AI Cancer Advisory Group on 12th June 2026

BOPA AI CAG contribute to the National Commission into the Regulation of AI in Healthcare: research, engagement and call for evidence findings

Recently, the MHRA invited feedback from individuals and organisations on the regulation of AI in healthcare across the UK. The BOPA AI CAG responded to this call for evidence, and…

Read article
By BOPA on 11th June 2026

Call for BOPA Award nominations

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article
By BOPA on 10th June 2026

New BOPA forum for Clinical Trials

We are pleased to share that a new national forum for oncology and haematology clinical trials pharmacy is now live for BOPA members. As many of you know, working in…

Read article